Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Saba Afzal, MD

Articles by Saba Afzal, MD

mood disorders

Lithium: Past, Present, and Future

BySehar Raza, MD,Stacy Doumas, MD, MBA,Saba Afzal, MD

May 24th 2023

Lithium: A Narrative Overview and Future Frontiers

BySehar Raza, MD,Stacy Doumas, MD, MBA,Saba Afzal, MD

March 8th 2023

Lithium: what’s its history and where do we still need more information?

Mask-wearing can help protect individuals from COVID-19 infection—but it also has several other unexpected advantages.

The Benefits of Wearing Personal Protective Equipment During the Pandemic

BySuneeta Kumari, MD, MPH, CCDS,Saba Afzal, MD,Stacy Doumas, MD, MBA,Eric Alcera, MD,Ramon Solhkhah, MD

June 28th 2022

Mask-wearing can help protect individuals from COVID-19 infection—but it also has several other unexpected advantages.

Latest Updated Articles

Lithium: A Narrative Overview and Future Frontiers
March 8th 2023

Trending on Psychiatric Times

Olanzapine LAI (Weltruza) Receives FDA Approval for Schizophrenia

Moving Away From Treatment-Resistant Depression and Toward Difficult-to-Treat Depression

Blood-Based Biomarkers for Alzheimer Disease: Accuracy, Limits, and Confounders

Should Postpartum Psychosis Be Included in the DSM?

Blinding, Ethics, and Safety Safeguards in Psychedelic Clinical Research